William Canestaro holds the position of Managing Director at Washington Research Foundation (WRF) and is a Member of the Board of Directors at Phase Genomics. In his role as Managing Director at WRF Capital, he leads a team that invests in early-stage biotechnology companies in the life sciences sector. With a decade of experience in biotechnology encompassing investment, management, consulting, and research roles, he specializes in health economics, market analysis, business development, and strategic partnerships. He is dedicated to driving innovative solutions that enhance health outcomes and address medical gaps, and his involvement includes serving as a board member, advisor, and faculty member in various healthcare and biotech organizations. Notably, he has invested in SEngine Precision Medicine, a company utilizing 3D organoid technology and algorithms to develop more effective drugs.